- BrandВетеринарные препараты
- Country of manufactureRussia
Iodtriethylenglicolum - contains iodium - 4% as the active ingredient and potassium iodide - 0.08%, potassium iodate - 0.12%, hydrochloric acid - 2.6% and triethyleneglycol - 100 %
as auxiliary ingredients.
1.GENERAL INFORMATION
1.1. Provided the storage conditions are observed, the shelf life of Iodine triethylene glycol (ITEG)- A, is 3 years from the date of release
1.2. Iodine triethylene glycol (ITEG)-A contains iodium - 4% as the active ingredient and potassium iodide - 0.08%, potassium iodate - 0.12%, hydrochloric acid - 2.6% and triethyleneglycol - 100 % as auxiliary ingredients.
1.3. The unused drug preparation is disposed of in accordance with the legislation requirements.
Externally, Iodine triethylene glycol (ITEG)-A is a homogeneous liquid, dark-red in color with iodine odor. Iodine triethylene glycol (ITEG)-A is packaged in tightly sealed glass bottles, jars, vials, as well as in plastic vials and jars with screw-on caps.
2.PHARMACOLOGICAL PROPERTIES
2.1. When used as an aerosol, Iodine triethylene glycol (ITEG)-A sanitizes the air and has a local antiseptic and anti-inflammatory effect on the breathing organs of animals and birds.
2.2. Iodine triethylene glycol (ITEG)-A belongs to the antiseptics group, produces an antibacterial effect on Gram-negative and Gram-positive organisms, including pathogens of colibacillosis,
3. USAGE PROCEDURE
3.1. Increased individual sensitivity of animals to iodine and other preparation ingredients is a contraindication to the use of Iodine triethylene glycol (ITEG)-A.
3.2. The working solution of Iodine triethylene glycol (ITEG)-A is prepared under the supervision of a veterinarian or veterinary paramedic by mixing Iodine triethylene glycol (ITEG)-A with water in the ratio of 1:1 immediately before use and used only on the day of its preparation. The volume of the working solution needed for the processing of the premises and the amount of Iodine triethylene glycol (ITEG)-A required for its preparation is thereby determined.
3.3. No symptoms of Iodine triethylene glycol (ITEG)-A overdose have been identified.
3.4. No special features of the effect of the drug preparation during its first application and its cancellation have been identified.
